Mirion Technologies, Inc. engages in the provision of nuclear measurement and detection systems. The company is headquartered in Atlanta, Georgia and currently employs 2,872 full-time employees. The company went IPO on 2020-06-29. The Company’s segments include Medical and Industrial. The Medical segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Industrial segment is focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, defense, laboratories and research and other industrial markets. Its products and solutions of its Medical segment and of its Industrial segment include dosimetry services, cancer diagnostics and therapy assurance, nuclear medicine, dosimeters, contamination and clearance monitors, detection and identification instruments, radiation monitoring systems and electrical penetrations. The company also provides reactor instrumentation and control equipment and systems, medical and industrial imaging systems and others.